PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
Satishkumar, N., Alexander, J.A.N., Poon, R., Buggeln, E., Argudin, M.A., Strynadka, N.C.J., Chatterjee, S.S.(2021) J Antimicrob Chemother 76: 2268-2272
- PubMed: 34151961 
- DOI: https://doi.org/10.1093/jac/dkab201
- Primary Citation of Related Structures:  
7KCV, 7KCW, 7KCX, 7KCY - PubMed Abstract: 
PBP4, a low-molecular-weight PBP in Staphylococcus aureus, is not considered to be a classical mediator of β-lactam resistance. Previous studies carried out by our group with laboratory strains of S. aureus demonstrated the ability of PBP4 to produce β-lactam resistance through mutations associated with the pbp4 promoter and/or gene. Recent studies of β-lactam-resistant clinical isolates of S. aureus have reported similar mutations associated with pbp4.
Organizational Affiliation: 
Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.